Clinical Trial: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

Brief Summary: The purpose of this research study is to determine if two investigational medications will be more effective in decreasing urine output than the currently available and routinely used medications in patients with congenital nephrogenic diabetes insipidus (NDI).